Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Bowel Movement in Laparoscopic Gastrectomy
NCT02164448Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in gastric cancer (GC) (2 arms), sponsored by Yonsei University. Primary endpoint: Time to gas passing up to 1 week. Started Jun 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02164448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164448.